These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24920174)

  • 21. Transforming growth factor‑β1 induces epithelial‑mesenchymal transition and increased expression of matrix metalloproteinase‑16 via miR‑200b downregulation in bladder cancer cells.
    Chen MF; Zeng F; Qi L; Zu XB; Wang J; Liu LF; Li Y
    Mol Med Rep; 2014 Sep; 10(3):1549-54. PubMed ID: 25017509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. nm23-H1 is a negative regulator of TGF-β1-dependent induction of epithelial-mesenchymal transition.
    Zhao R; Gong L; Li L; Guo L; Zhu D; Wu Z; Zhou Q
    Exp Cell Res; 2013 Mar; 319(5):740-9. PubMed ID: 23137649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epithelial to mesenchymal transition might be induced via CD44 isoform switching in colorectal cancer.
    Mashita N; Yamada S; Nakayama G; Tanaka C; Iwata N; Kanda M; Kobayashi D; Fujii T; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Kodera Y
    J Surg Oncol; 2014 Nov; 110(6):745-51. PubMed ID: 24975268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arctii Fructus Inhibits Colorectal Cancer Cell Proliferation and MMPs Mediated Invasion via AMPK.
    Han YH; Kee JY; Kim DS; Mun JG; Park SH; Kim YJ; Um JY; Hong SH
    Am J Chin Med; 2017; 45(6):1309-1325. PubMed ID: 28830210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Docosahexaenoic acid inhibits the invasion and migration of colorectal cancer by reversing EMT through the TGF-β1/Smad signaling pathway.
    Jiang YL; Li X; Tan YW; Fang YJ; Liu KY; Wang YF; Ma T; Ou QJ; Zhang CX
    Food Funct; 2024 Sep; 15(18):9420-9433. PubMed ID: 39189524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1α,25(OH)₂D₃ Suppresses the Migration of Ovarian Cancer SKOV-3 Cells through the Inhibition of Epithelial-Mesenchymal Transition.
    Hou YF; Gao SH; Wang P; Zhang HM; Liu LZ; Ye MX; Zhou GM; Zhang ZL; Li BY
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27548154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NF-κBP65 promotes invasion and metastasis of oesophageal squamous cell cancer by regulating matrix metalloproteinase-9 and epithelial-to-mesenchymal transition.
    Wang F; He W; Fanghui P; Wang L; Fan Q
    Cell Biol Int; 2013 Aug; 37(8):780-8. PubMed ID: 23504993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA‑500a‑5p inhibits colorectal cancer cell invasion and epithelial‑mesenchymal transition.
    Tang W; Hong L; Dai W; Li J; Zhu H; Lin J; Yang Q; Wang Y; Lin Z; Liu M; Xiao Y; Zhang Y; Wu X; Wang J; Chen Y; Hu H; Liu S; Wang J; Xiang L
    Int J Oncol; 2020 Jun; 56(6):1499-1508. PubMed ID: 32236592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
    Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J
    Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin K3 (menadione) suppresses epithelial-mesenchymal-transition and Wnt signaling pathway in human colorectal cancer cells.
    Kishore C; Sundaram S; Karunagaran D
    Chem Biol Interact; 2019 Aug; 309():108725. PubMed ID: 31238027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 20(S)-ginsenoside Rh2 as agent for the treatment of LMN-CRC via regulating epithelial-mesenchymal transition.
    Yuan Y; Wang J; Xu M; Zhang Y; Wang Z; Liang L; Sun P
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32141497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peroxiredoxin 5 promotes the epithelial-mesenchymal transition in colon cancer.
    Ahn HM; Yoo JW; Lee S; Lee HJ; Lee HS; Lee DS
    Biochem Biophys Res Commun; 2017 Jun; 487(3):580-586. PubMed ID: 28431931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucocorticoid induces mesenchymal-to-epithelial transition and inhibits TGF-β1-induced epithelial-to-mesenchymal transition and cell migration.
    Zhang L; Lei W; Wang X; Tang Y; Song J
    FEBS Lett; 2010 Nov; 584(22):4646-54. PubMed ID: 20971111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of CD147 promotes cell invasion, epithelial-to-mesenchymal transition and activates MAPK/ERK signaling pathway in colorectal cancer.
    Xu T; Zhou M; Peng L; Kong S; Miao R; Shi Y; Sheng H; Li L
    Int J Clin Exp Pathol; 2014; 7(11):7432-41. PubMed ID: 25550778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TGF-beta1 causes epithelial-mesenchymal transition in HaCaT derivatives, but induces expression of COX-2 and migration only in benign, not in malignant keratinocytes.
    Räsänen K; Vaheri A
    J Dermatol Sci; 2010 May; 58(2):97-104. PubMed ID: 20399617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peroxiredoxin 2 is associated with colorectal cancer progression and poor survival of patients.
    Peng L; Wang R; Shang J; Xiong Y; Fu Z
    Oncotarget; 2017 Feb; 8(9):15057-15070. PubMed ID: 28125800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knockdown of Y‑box‑binding protein‑1 inhibits the malignant progression of HT‑29 colorectal adenocarcinoma cells by reversing epithelial‑mesenchymal transition.
    Yan XB; Zhu QC; Chen HQ; Peng JY; Chao HL; Du HX; Wang ZG; Jin ZM
    Mol Med Rep; 2014 Nov; 10(5):2720-8. PubMed ID: 25201740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CDX2 as a Predictive Biomarker Involved in Immunotherapy Response Suppresses Metastasis through EMT in Colorectal Cancer.
    Wang YS; Kou Y; Zhu RT; Han BW; Li CH; Wang HJ; Wu HB; Xia TM; Che XM
    Dis Markers; 2022; 2022():9025668. PubMed ID: 36277982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peroxiredoxin 2 is upregulated in colorectal cancer and contributes to colorectal cancer cells' survival by protecting cells from oxidative stress.
    Lu W; Fu Z; Wang H; Feng J; Wei J; Guo J
    Mol Cell Biochem; 2014 Feb; 387(1-2):261-70. PubMed ID: 24234423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Berberine reverses epithelial-to-mesenchymal transition and inhibits metastasis and tumor-induced angiogenesis in human cervical cancer cells.
    Chu SC; Yu CC; Hsu LS; Chen KS; Su MY; Chen PN
    Mol Pharmacol; 2014 Dec; 86(6):609-23. PubMed ID: 25217495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.